DALMONAR 2mg/mL CONCENTRADO PARA SOLUCION PARA PERFUSION Perú - espanyol - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

dalmonar 2mg/ml concentrado para solucion para perfusion

global med farma s.a.c. - droguerÍa - concentrado para solucion para perfusion - por vial - - doxorubicina

Skytrofa (previously Lonapegsomatropin Ascendis Pharma) Unió Europea - espanyol - EMA (European Medicines Agency)

skytrofa (previously lonapegsomatropin ascendis pharma)

ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hormonas hipofisarias e hipotalámicas y análogos - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.

HAMSYL® 3750UI/5mL SOLUCION INYECTABLE Perú - espanyol - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

hamsyl® 3750ui/5ml solucion inyectable

emcure pharma peru sociedad anonima cerrada - droguerÍa - solucion inyectable - por vial - - pegaspargasa

Zolsketil pegylated liposomal Unió Europea - espanyol - EMA (European Medicines Agency)

zolsketil pegylated liposomal

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

SPIKEVAX SUSPENSIÓN INYECTABLE 25/25 µg/dosis (VACUNA SARS-CoV-2 ARNm DAVESOMERAN/ELASOMERAN) Xile - espanyol - ISPC (Instituto de Salud Pública de Chile)

spikevax suspensión inyectable 25/25 µg/dosis (vacuna sars-cov-2 arnm davesomeran/elasomeran)

tecnofarma s.a. - davesomeran; elasomeran - davesomerÁn (1) 25 mcg; elasomerÁn (2) 25 mcg - indicada para la inmunización activa para prevenir el covid-19, causada por el virus sars-cov-2, en personas de 6 años y mayores que han recibido previamente al menos la primovacunación contra covid-19.

SPIKEVAX SUSPENSIÓN INYECTABLE 25/25 µg/dosis (VACUNA SARS-CoV-2 ARNm DAVESOMERAN/ELASOMERAN) Xile - espanyol - ISPC (Instituto de Salud Pública de Chile)

spikevax suspensión inyectable 25/25 µg/dosis (vacuna sars-cov-2 arnm davesomeran/elasomeran)

tecnofarma s.a. - davesomeran; elasomeran - davesomerÁn (1) 25 mcg; elasomerÁn (2) 25 mcg - indicada para la inmunización activa para prevenir el covid-19, causada por el virus sars-cov-2, en personas de 6 años y mayores que han recibido previamente al menos la primovacunación contra covid-19.